What is it about?

Tarsal tunnel syndrome is characterized by a wide array of neurologic symptoms extending from the bottom of the toes, ball and arch of the foot, heel and proximally into the lower leg. Most cases are diagnosed as idiopathic but a strong pathomechanic etiology has been named as the leading cause of this disorder. Increased pressure within the tarsal tunnel and/or the porta pedis will lead to negative effects on the posterior tibial nerve. Displacement of the talus on the tarsal mechanism has been theorized to increase the pressures in the tarsal tunnel and porta pedis. A pressure of 25-30 mmHg or greater has been proven to impair intraneural blood flow. Therefore, stabilization of any existing pathologic mal-alignment of the talotarsal mechanism should lead to a decrease in these pressures and could lead to alleviation of the associated symptoms. Surgery to decompress the tarsal tunnel has historically been linked with a significant recurrence rate. Methods: Pressures in the tarsal tunnel and porta pedis were measured in 9 fresh-frozen cadaver specimens using an intracompartmental pressure monitor system.  Pressures were measured with the foot in the neutral and the hyperpronated position, before and after stabilization using HyProCure®.  The blinded sub-investigator was instructed to maximally pronate the talotarsal mechanism by applying maximum force to the 4th & 5th metatarsal heads. A pressure sensor was placed under the 4th & 5th metatarsal heads ensuring that the same maximum pressure was applied for each reading. Results: The pressure within the tarsal tunnel with the hindfoot in neutral position with and without HyProCure® was 3 ± 3 mm Hg and 4 ± 3 mm Hg, respectively (P = .159).  Upon maximum hindfoot pronation without stabilization, the pressure increased to an average of 32 ± 16 mm Hg  Following the placement of HyProCure®, the pressures decreased to 21 ± 10 mm Hg (P < .001).  The pressure in the porta pedis with the hindfoot in neutral position with and without HyProCure® was 2 ± 2 mm Hg and 2 ± 2 mm Hg, respectively (P = .168).  Upon maximum hindfoot pronation without stabilization, the pressure rose on average to 29 ± 15 mm Hg.  Following the placement of HyProCure®, the pressures normalized to 18 ± 11 mm Hg (P < .001).

Featured Image

Why is it important?

The primary goal of this study was to quantify the effect of extra-osseous talotarsal stabilization (EOTTS) using the HyProCure® device on pressure within both the tarsal tunnel and porta pedis. It was hypothesized that these pressures would decrease following EOTTS.

Perspectives

Talotarsal dislocation (partial) leads to excessive hindfoot motion contributing to elevated pressures within the tarsal tunnel and porta pedis. Pressures greater than 25 mmHg have been shown to decrease blood flow within the nerve. Decreased blood flow has been named an etiologic factor of neuropathy. HyProCure® has been scientifically proven to significantly decrease the pressures within both the tarsal tunnel and porta pedis

Dr. Michael E Graham
Graham International Implant Institute

Read the Original

This page is a summary of: The Effect of HyProCure® Sinus Tarsi Stent on Tarsal Tunnel Compartment Pressures in Hyperpronating Feet, The Journal of Foot & Ankle Surgery, January 2011, Elsevier,
DOI: 10.1053/j.jfas.2010.10.002.
You can read the full text:

Read

Contributors

The following have contributed to this page